China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$2.41 -0.55 (-18.58%)
At close: Oct 2, 2026 · 4:00 PM EDT

China SXT Pharmaceuticals (SXTC) Net Income (2017 - 2019)

Updated

China SXT Pharmaceuticals' Net Income came in at -$5.33 million for FY2026 (year ended Mar 31, 2026), compared with -$3.35 million in FY2025.

Analysis

China SXT Pharmaceuticals (SXTC) Net Income (2017 - 2019) Analysis & Trends

Going back to FY2017, China SXT Pharmaceuticals' Net Income data covers 10 fiscal years.

  • The FY2026 figure represents the lowest annual Net Income since FY2023.
  • Per Business Quant, earlier fiscal years put Net Income at -$3.35 million in FY2025, -$3.93 million in FY2024, -$7.09 million in FY2023 and -$5.31 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 5.53 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.62 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 2.51 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -10.50 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -237.00 Mn
10 China SXT Pharmaceuticals 38,844.08 -85.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -1.17 Mn
Dec 31, 2018 1.19 Mn
Mar 31, 2018 -541,655.00
Dec 31, 2017 1.19 Mn
API Access

China SXT Pharmaceuticals Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=SXTC&period=max&api_key=YOUR_API_KEY